Last reviewed · How we verify
NCT05846477: MC vs STD
MySpine MC Versus MySpine Standard
trial testing MySpine in Degenerative Disc Disease in 44 participants. Status unknown.
28 February 2024
Quick facts
| Lead sponsor | Medacta International SA |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 44 |
| Start date | 4 February 2021 |
| Primary completion | 28 February 2024 |
| Estimated completion | 28 February 2024 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- MySpine
Conditions studied
- Degenerative Disc Disease — all drugs for Degenerative Disc Disease →
- Osteochondrosis — all drugs for Osteochondrosis →
- Spondylolysis Lumbar — all drugs for Spondylolysis Lumbar →
Sponsor
Medacta International SA — full company profile →
Who can join
18 and older, any sex, with Degenerative Disc Disease or Osteochondrosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research project compares the clinical performance of the cortical bone trajectory CBT insertion technique with the current clinical Gold standard, the Pedicle screw insertion technique. Both techniques are performed by aid of MySpine patient-specific guide systems.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05846477
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Degenerative Disc Disease
Currently open trials in the same condition.
- NCT07254806 — A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to · Phase 3 · recruiting
- NCT04679844 — Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Au · NA · recruiting
- NCT06704919 — Conduit Cages and Fibergraft BG Putty · recruiting
- NCT06053242 — Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Ba · Phase 1, PHASE2 · recruiting
- NCT03810573 — Evaluation of NB1 Bone Graft Following Lumbar Interbody Arthrodesis · NA · recruiting
Other Medacta International SA trials
Trials by the same sponsor.
- NCT06775704 — Clinical and Radiological Outcomes of the ROMAX Hip Resurfacing System · recruiting
- NCT06640764 — Multicentre SMS Study - FR · recruiting
- NCT06578897 — A Post-Market, Retrospective Study on 3D Metal Tibial and Femoral Cones · completed
- NCT05679232 — Hydrogel Coating to Reduce Post-surgical Infection After Joint Arthroplasty · NA · recruiting
- NCT05785364 — A Post Market Surveillance Study About the MONOCER Cup · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05846477 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medacta International SA
- Last refreshed: 6 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05846477.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing